{"id":48186,"date":"2024-01-12T14:12:26","date_gmt":"2024-01-12T06:12:26","guid":{"rendered":"https:\/\/biopioneer.com.tw\/?p=48186"},"modified":"2025-08-29T18:28:33","modified_gmt":"2025-08-29T10:28:33","slug":"rituximab-anti-cd20-%e5%88%a9%e5%a6%a5%e6%98%94%e5%96%ae%e6%8a%97%ef%bc%88%e6%8a%97-cd20%ef%bc%89-cas174722-31-7-mce%e8%b2%a8%e8%99%9fhy-p9913a","status":"publish","type":"post","link":"https:\/\/biopioneer.com.tw\/?p=48186","title":{"rendered":"Rituximab (anti-CD20) \u5229\u59a5\u6614\u55ae\u6297\uff08\u6297 CD20\uff09 | CAS#174722-31-7 MCE\u8ca8\u865fHY-P9913A"},"content":{"rendered":"

\u7814\u7a76\u7d1a\u751f\u7269\u76f8\u4f3c\u85e5\u6297\u9ad4(research-grade biosimilar antibodies)<\/span>\u00a0<\/strong><\/span><\/p>\n

MedChemExpress (MCE) \u6291\u5236\u6027\u6297\u9ad4(Inhibitory Antibodies )\u662f\u7814\u7a76\u7d1a\u751f\u7269\u76f8\u4f3c\u85e5\u6297\u9ad4(research-grade biosimilar antibodies)\uff0c\u5177\u6709\u8207\u539f\u59cb\u6cbb\u7642\u6297\u9ad4\u76f8\u540c\u7684\u751f\u7269\u6d3b\u6027\u6210\u5206(bioactive component)\u3002\u751f\u7269\u76f8\u4f3c\u85e5( Biosimilar)\u4f7f\u5f97\u7814\u7a76\u85e5\u7269\u7684\u751f\u7269\u6548\u61c9\u6210\u70ba\u53ef\u80fd\u3002\u9019\u4e9b\u6297\u9ad4\u7279\u7570\u6027\u7d50\u5408\u6a19\u9776\u7d30\u80de\u6216\u86cb\u767d\u8cea\uff0c\u523a\u6fc0\u514d\u75ab\u7cfb\u7d71\u653b\u64ca\u60e1\u6027\u816b\u7624\u7d30\u80de\u6216\u963b\u65b7\u7279\u5b9a\u7d30\u80de\u53d7\u9ad4\u4f86\u963b\u6b62\u816b\u7624\u751f\u9577\u3002\u6a19\u9776\u86cb\u767d\u5305\u62ecCD20\u3001HER2\u3001EGFR\u3001VEGFR\u3001TNF-\u03b1\u7b49\u3002MCE\u6291\u5236\u6297\u9ad4\u5df2\u5ee3\u6cdb\u61c9\u7528\u65bc\u764c\u75c7(cancer)\u3001\u514d\u75ab\u5b78(immunology )\u548c\u611f\u67d3(infection)\u7b49\u6700\u71b1\u9580\u7684\u7814\u7a76\u9818\u57df\u3002<\/p>\n

MCE \u6291\u5236\u6297\u9ad4(MCE Inhibitory Antibodies)\u662f\u55ae\u682a\u6297\u9ad4 (mAb)\uff0c\u5df2\u5ee3\u6cdb\u61c9\u7528\u65bc\u764c\u75c7(cancer)\u3001\u514d\u75ab\u5b78( immunology )\u548c\u611f\u67d3(infection)\u7b49\u6700\u71b1\u9580\u7684\u7814\u7a76\u9818\u57df\u3002\u9019\u4e9b\u55ae\u682a\u6297\u9ad4\uff08mAb\uff09\u55ae\u4e00\u7279\u7570\u6027\u5730\u8207\u67d0\u4e9b\u7d30\u80de\u6216\u86cb\u767d\u8cea\u7d50\u5408\uff0c\u5f9e\u800c\u523a\u6fc0\u514d\u75ab\u7cfb\u7d71\u653b\u64ca\u60e1\u6027\u816b\u7624\u7d30\u80de\uff0c\u4e26\u900f\u904e\u963b\u65b7\u7279\u5b9a\u7684\u7d30\u80de\u53d7\u9ad4\u4f86\u9632\u6b62\u816b\u7624\u751f\u9577\u3002\u5b83\u5011\u53ef\u4ee5\u6291\u5236PD-1\u3001PD-L1\u3001EGFR\u3001VEGFR\u3001TNF-\u03b1 \u6216\u5176\u4ed6\u5728\u75be\u75c5\u4e2d\u7570\u5e38\u6d3b\u8e8d\u7684\u9776\u9ede\uff0c\u4f8b\u5982\u975e\u4f55\u6770\u91d1\u6c0f\u6dcb\u5df4\u7624(non-Hodgkin lymphom)\u3001A \u578b\u8840\u53cb\u75c5( Hemophilia A)\u3001\u814e\u7d30\u80de\u764c(renal cell carcinoma)\u3001\u5e15\u91d1\u68ee\u6c0f\u75c7(Parkinson’s disease)\u548c\u8f49\u79fb\u6027HER2 \u967d\u6027\u4e73\u764c\u764c\u75c7(metastatic HER2-positive breast cancer)\u3002\u4f8b\u5982\uff0c\u900f\u904e\u8207 VEGF \u7d50\u5408\uff0c\u8c9d\u4f10\u55ae\u6297(Bevacizumab )\u53ef\u9632\u6b62 VEGF \u8207\u5176\u53d7\u9ad4\u76f8\u4e92\u4f5c\u7528\uff0c\u5f9e\u800c\u6291\u5236\u65b0\u8840\u7ba1\u751f\u9577(inhibiting new vessel growth)\u3002\u862d\u535a\u5229\u73e0\u55ae\u6297(Lambrolizumab)\u9776\u5411\u6dcb\u5df4\u7d30\u80de\u7684\u7a0b\u5e8f\u6027\u7d30\u80de\u6b7b\u4ea1 1 (PD-1) \u53d7\u9ad4\u3002\u900f\u904e\u963b\u6b62\u5176\u914d\u9ad4\uff08PD-L1 \u548c PD-L2\uff09\u7684\u7d50\u5408\uff0cLambrolizumab \u8a98\u5c0e\u6297\u816b\u7624\u514d\u75ab\u53cd\u61c9\u3002<\/p>\n

Rituximab (anti-CD20) \u5229\u59a5\u6614\u55ae\u6297\uff08\u6297 CD20\uff09 | CAS#174722-31-7 MCE\u8ca8\u865fHY-P9913A 99.00%<\/a><\/span><\/strong><\/span><\/p>\n

\n
\n

\u5229\u59a5\u6614\u55ae\u6297\uff08\u6297 CD20\uff09\u662f\u4e00\u7a2e\u6297 CD20 \u5d4c\u5408\u55ae\u682a\u6297\u9ad4(chimeric monoclonal antibody)\uff0c\u7528\u65bc\u6cbb\u7642\u67d0\u4e9b\u81ea\u9ad4\u514d\u75ab\u75be\u75c5(autoimmune diseases )\u548c\u764c\u75c7\u985e\u578b\u3002
\nRituximab\uff08\u6297 CD20\uff09\u53ef\u6291\u5236\u53d7\u523a\u6fc0\u7684\u4eba\u985e B \u7d30\u80de\u7684\u589e\u6b96(proliferation)\uff0c\u9019\u8207\u5177\u6709\u6d3b\u5316\u7684\u521d\u59cb\u8868\u578b\u7684 B \u7d30\u80de\u76f8\u5c0d\u589e\u52a0\u6709\u95dc\u3002\u9664\u4e86\u9019\u7a2e\u7fa4\u9ad4\u8f49\u8b8a\u4e4b\u5916\uff0c\u5404\u7a2e B \u7d30\u80de\u4e9e\u7fa4\u7684\u8868\u578b\u6216\u7d30\u80de\u6fc0\u7d20\u8b5c\u6c92\u6709\u91cd\u5927\u8b8a\u5316\u3002\u8207\u4e0d\u5b58\u5728\u5229\u59a5\u6614\u55ae\u6297\u7684\u60c5\u6cc1\u4e0b\u523a\u6fc0\u7684 B \u7d30\u80de\u76f8\u6bd4\uff0c\u5728\u5b58\u5728\u5229\u59a5\u6614\u55ae\u6297\u7684\u60c5\u6cc1\u4e0b\u523a\u6fc0\u7684 B \u7d30\u80de\u53ef\u8a98\u5c0e\u66f4\u5f37\u7684 T \u7d30\u80de\u589e\u6b96[1]\u3002\u6240\u6709\u6e2c\u8a66\u7684\u6dcb\u5df4\u7624\u7d30\u80de\u5c0d\u6297\u9ad4\u4f9d\u8cf4\u6027\u7d30\u80de\u4ecb\u5c0e\u7684\u7d30\u80de\u6bd2\u6027\uff08ADCC\uff09\u3001\u6297\u9ad4\u4ecb\u5c0e\u7684\u816b\u7624\u7d30\u80de\u541e\u566c\u4f5c\u7528\u548c\u5229\u59a5\u6614\u55ae\u6297\u8a98\u5c0e\u7684\u7d30\u80de\u51cb\u4ea1\u540c\u6a23\u654f\u611f\u3002 Rituximab\uff08\u6297 CD20\uff09\u53ef\u8a98\u5c0e CDC \u5c0d\u6ffe\u6ce1\u6027\u6dcb\u5df4\u7624\u7d30\u80de\u7684\u9ad8\u5ea6\u6bba\u50b7[2]\u3002<\/p>\n\n\n\n\n\n\n\n
Molecular Weight<\/th>\n\n
\n

144544.44<\/p>\n<\/div>\n<\/td>\n<\/tr>\n

CAS No.<\/th>\n\n
Appearance<\/th>\n\n
\n

Liquid<\/p>\n<\/div>\n<\/td>\n<\/tr>\n

Color<\/th>\n\n
\n

Colorless to light yellow<\/p>\n<\/div>\n<\/td>\n<\/tr>\n

SMILES<\/th>\n\n
\n

[Rituximab (anti-CD20)]<\/p>\n<\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/div>\n
\n
\n
<\/div>\n
Long non-coding RNA (LncRNA) CHROMR promotes the expression of the CNNM1 gene by adsorbing hsa-miR-1299 to obtain drug resistance in diffuse large B lymphoma cells<\/div>\n<\/div>\n<\/div>\n
Read Article\u00a0<\/a><\/div>\n

6 Publications Citing Use of MCE Rituximab (anti-CD20)<\/span><\/h2>\n

MedChemexpress (MCE) \u7522\u54c1-\u7814\u7a76\u7d1a\u751f\u7269\u76f8\u4f3c\u85e5\u6297\u9ad4<\/span><\/strong><\/span><\/h4>\n\n\n\n\n\n\n\n\n\n\n\n
\u5316\u5408\u7269\u54c1\u724c<\/td>\n\u5316\u5408\u7269CAS\u865f<\/td>\n\u5316\u5408\u7269\u540d\u7a31<\/td>\n\u5316\u5408\u7269\u8ca8\u865f<\/td>\n\u5316\u5408\u7269\u4ecb\u7d39<\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#1496553<\/a><\/td>\nZolbetuximab (IMAB362) \u4e00\u7a2e\u91dd\u5c0d Claudin-18.2 \u7684\u55ae\u682a\u6297\u9ad4\u3002 Zolbetuximab (IMAB362) \u900f\u904e\u514d\u75ab\u6548\u61c9\u6a5f\u5236\u4ecb\u5c0e Claudin-18.2 \u967d\u6027\u7d30\u80de\u7684\u7279\u7570\u6027\u6bba\u50b7\u3002 Zolbetuximab \u53ef\u7528\u65bc\u80c3\u8178\u9053\u817a\u764c(gastrointestinal adenocarcinomas )\u548c\u80f0\u817a\u816b\u7624( pancreatic tumors)\u7684\u7814\u7a76\u3002<\/td>\nMCE\u8ca8\u865fHY-P99058<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#174722-31-7<\/td>\nRituximab (anti-CD20) \u5229\u59a5\u6614\u55ae\u6297\uff08\u6297 CD20\uff09\u662f\u4e00\u7a2e\u6297 CD20 \u5d4c\u5408\u55ae\u682a\u6297\u9ad4(chimeric monoclonal antibody)\uff0c\u7528\u65bc\u6cbb\u7642\u67d0\u4e9b\u81ea\u9ad4\u514d\u75ab\u75be\u75c5(autoimmune diseases )\u548c\u764c\u75c7\u985e\u578b\u3002<\/td>\nMCE\u8ca8\u865fHY-P9913A<\/td>\n\n

\u7522\u54c1\u9023\u7d50<\/span><\/a><\/p>\n

 <\/td>\n<\/tr>\n

MCE(MedChemexpress)<\/td>\nCAS#216974-75-3<\/td>\nBevacizumab (PBS)\u662f\u4e00\u7a2e\u4eba\u6e90\u5316\u00a0IgG1\u00a0\u55ae\u682a\u6297\u9ad4\uff0c\u4ee5\u9ad8\u89aa\u548c\u529b\u7279\u7570\u6027\u7d50\u5408\u6240\u6709 \u00a0VEGF-A\u4e9e\u578b\u3002\u8c9d\u4f10\u73e0\u55ae\u6297(Bevacizumab)\u662f\u4e00\u7a2e\u4eba\u6e90\u5316\u55ae\u682a\u6297\u9ad4\uff0c\u4ee5\u9ad8\u89aa\u548c\u529b\u7279\u7570\u6027\u7d50\u5408\u6240\u6709 VEGF-A \u4e9e\u578b\uff0c\u4e26\u6291\u5236\u5176\u8207 VEGFR-1 \u548c VEGFR-2 \u7684\u76f8\u4e92\u4f5c\u7528[1]<\/td>\nMCE\u8ca8\u865fHY-P9906A<\/td>\n\u7522\u54c1\u9023\u7d50<\/span><\/a><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#180288-69-1<\/td>\n\u66f2\u59a5\u73e0\u55ae\u6297(Trastuzumab)\u662f\u4e00\u7a2e\u4eba\u6e90\u5316 IgG1 \u55ae\u682a\u6297\u9ad4\uff0c\u9069\u7528\u65bc HER2 \u904e\u5ea6\u8868\u73fe\u7684\u4fb5\u8972\u6027\u4e73\u764c\u60a3\u8005(invasive breast cancers)\u3002\u66f2\u59a5\u73e0\u55ae\u6297(Trastuzumab)\u5177\u6709 HER2 \u967d\u6027\u8f49\u79fb\u6027\u4e73\u764c(HER2 Positive Metastatic Breast\u00a0Cancer<\/a> )\u548c HER2 \u967d\u6027\u80c3\u764c(HER2 Positive Gastric\u00a0Cancer<\/a> )\u7814\u7a76\u7684\u6f5b\u529b\u3002<\/td>\nMCE\u8ca8\u865fHY-P9907<\/td>\n\u7522\u54c1\u9023\u7d50<\/span><\/a><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#1374853-91-4<\/td>\nPembrolizumab (MK-3475) \u53ef\u6291\u5236\u7a0b\u5e8f\u6027\u7d30\u80de\u6b7b\u4ea1 1 (programmed cell death 1, PD-1) \u53d7\u9ad4\uff0c\u7528\u65bc\u764c\u75c7\u514d\u75ab\u6cbb\u7642(cancer immunotherapy<\/a>)\u3002Pembrolizumab (MK-3475)
\nPembrolizumab (MK-3475)\u589e\u52a0\u7d30\u80de\u6fc0\u7d20 IFN-\u03b3(cytokines IFN-\u03b3)\u3001TNF-\u03b1 \u7684\u5206\u6ccc\u4ee5\u53ca A549 \u7d30\u80de(\u4eba\u985e\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u7d30\u80de\u682a, A549) \u7684\u51cb\u4ea1\u7d30\u80de\u6b7b\u4ea1[2]\u3002 Pembrolizumab \u53ef\u6539\u5584\u03b1ROR1-CAR T \u4ecb\u5c0e\u7684\u7d30\u80de\u6bd2\u6027\uff0c\u4e26\u900f\u904e\u963b\u65b7\u03b1ROR1-CAR T \u7d30\u80de\u4e2d\u7684PD-1::PD-L1 \u76f8\u4e92\u4f5c\u7528\u4f86\u6e1b\u5c11\u5171\u57f9\u990a\u7684\u03b1ROR1-CAR T \u548cA549 \u7d30\u80de(\u4eba\u985e\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u7d30\u80de\u682a, A549) \u4e2d\u7684\u816b\u7624\u767c\u751f[2]\u3002<\/td>\n		MCE\u8ca8\u865fHY-P9902<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#946414-94-4<\/td>\nNivolumab \u662f\u4e00\u7a2e\u7a0b\u5e8f\u6027\u6b7b\u4ea1\u53d7\u9ad4 1 (PD-1) \u963b\u65b7\u6027\u4eba\u985e IgG4 \u6297\u9ad4\uff0c\u7528\u65bc\u6cbb\u7642\u665a\u671f\uff08\u8f49\u79fb\u6027\uff09\u975e\u5c0f\u7d30\u80de\u80ba\u764c(non-small cell lung cancer)\u3002<\/td>\nMCE\u8ca8\u865fHY-P9903<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#1190264-60-8<\/td>\nDupilumab (REGN-668) \u662f\u4e00\u7a2e\u91dd\u5c0dIL-4 receptor<\/a>\u00a0<\/b>\u03b1 (IL-4R\u03b1) \u7684\u5168\u4eba\u6e90\u55ae\u682a\u6297\u9ad4\uff0c\u53ef\u6291\u5236IL-4<\/a><\/b>\u00a0 \u548c\u00a0IL-13<\/a><\/b>\u8a0a\u865f\u50b3\u5c0e\uff0c\u986f\u8457\u6539\u5584\u4e2d\u5ea6\u81f3\u91cd\u5ea6\u7570\u4f4d\u6027\u76ae\u819a\u708e\u3002<\/td>\nMCE\u8ca8\u865fHY-P9926<\/td>\n\u7522\u54c1\u9023\u7d50<\/span><\/a><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#656247-17-5<\/td>\nNintedanib (BIBF 1120) \u662f\u4e00\u7a2e\u6709\u6548\u7684\u4e09\u91cd\u8840\u7ba1\u6fc0\u9176\u6291\u5236\u5291(Triple angiokinase inhibitor)<\/td>\nMCE\u8ca8\u865fHY-50904<\/td>\n\u7522\u54c1\u9023\u7d50<\/span><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

\"\u7db2\u7ad9\u898f\u683c\u5c0f\u5716_\u5de5\u4f5c\u5340\u57df<\/a><\/h4>\n

MedChemexpress (MCE) \u7522\u54c1<\/span><\/h4>\n

MCE (MedChemexpress) \u7e3d\u90e8\u4f4d\u65bc\u7f8e\u570b\u65b0\u6fa4\u897f\uff0c\u63d0\u4f9b\u7a2e\u985e\u9f4a\u5168\u7684\u5316\u5b78\u53ca\u751f\u5316\u7814\u7a76\u7528\u7522\u54c1\uff0c\u5305\u62ec\u5275\u65b0\u7684\u751f\u547d\u79d1\u5b78\u8a66\u5291\uff0creference compounds (\u6a19\u6e96\u5316\u5408\u7269)\uff0cAPIs (\u539f\u6599\u85e5) \u53caNatural compounds (\u5929\u7136\u5316\u5408\u7269)\u4ee5\u63d0\u4f9b\u5be6\u9a57\u5ba4\u6216\u79d1\u5b78\u7814\u7a76\u4e4b\u7528\uff0cMedChemExpress(MCE)\u7522\u54c150000+ \u7279\u7570\u6027\u6291\u5236\u5291\u3001\u5316\u5408\u7269\u5eab\u3001\u91cd\u7d44\u86cb\u767d\uff0c\u5c08\u6ce8\u65bc\u4fe1\u865f\u901a\u8def\u548c\u75be\u75c5\u7814\u7a76\u9818\u57df\u3002\u5168\u7403\u6587\u737b\u5ee3\u6cdb\u5f15\u7528\uff0c\u8cea\u63a7\u9ad4\u7cfb\u56b4\u683c\uff0c\u54c1\u8cea100%\u3002\u5b98\u7db2\u9023\u7d50<\/span> https:\/\/www.medchemexpress.com<\/a><\/span><\/span><\/p>\n

<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u5316\u5408\u7269\u54c1\u724c<\/td>\n\u5316\u5408\u7269CAS\u865f<\/td>\n\u5316\u5408\u7269\u540d\u7a31<\/td>\n\u5316\u5408\u7269\u8ca8\u865f<\/td>\n\u5316\u5408\u7269\u4ecb\u7d39<\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#108321-42-2<\/td>\nG-418 disulfat<\/td>\nMCE\u8ca8\u865fHY-17561<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#68528-80-3<\/td>\nDSS Crosslinker (disuccinimidyl suberate)<\/td>\nMCE\u8ca8\u865fHY-W019543<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#1380723-44-3<\/td>\nAtezolizumab<\/td>\nMCE\u8ca8\u865fHY-P9904<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#1207456-01-6<\/td>\nTalazoparib (BMN-673; LT-673)<\/td>\nMCE\u8ca8\u865fHY-16106<\/span><\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#763113-22-0<\/td>\nOlaparib<\/td>\nMCE\u8ca8\u865fHY-10162<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#1382764-52-4<\/td>\nLipidGreen 2\u8102\u8cea\u6210\u50cf\u5c0f\u5206\u5b50\u63a2\u91dd<\/td>\nMCE\u8ca8\u865fHY-D1353<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#103404-75-7<\/td>\nD-\u87a2\u5149\u7d20(D-luciferin) \u6c34\u6eb6\u6027\u9209\u9e7d<\/td>\nMCE\u8ca8\u865fHY-12591<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#15144-35-9<\/td>\nD-\u87a2\u5149\u7d20(D-Luciferin potassium)<\/td>\nMCE\u8ca8\u865fHY-12591B<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#186689-07-6<\/td>\n2-NBDG\u6d3b\u7d30\u80de\u548c\u7d44\u7e54\u8461\u8404\u7cd6\u7684\u651d\u53d6<\/td>\nMCE\u8ca8\u865fHY-116215<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\n<\/td>\nIPTG\u00a0 ( Isopropyl \u03b2-D-thiogalactoside)<\/td>\nMCE\u8ca8\u865fHY-15921<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#10121-91-2<\/td>\n\u81ea\u566c\u6ce1(autophagic vacuoles)\u87a2\u5149\u6a19\u8a8c<\/td>\nMCE\u8ca8\u865fHY-D1027<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#28728-55-4<\/td>\n\u805a\u51dd\u80fa(Polybrene) \u967d\u96e2\u5b50\u805a\u5408\u7269<\/td>\nMCE\u8ca8\u865fHY-112735<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#288250-47-5<\/td>\nY-320 \u514d\u75ab\u8abf\u7bc0\u5291<\/td>\nMCE\u8ca8\u865fHY-15898<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#30931-67-0<\/td>\nABTS diammonium salt<\/td>\nMCE\u8ca8\u865fHY-15902<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#16561-29-8<\/td>\nPhorbol 12-myristate 13-acetate, PMA<\/td>\nMCE\u8ca8\u865fHY-18739<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#50-63-5<\/td>\n\u78f7\u9178\u6c2f\u55b9 Chloroquine phosphate<\/td>\nMCE\u8ca8\u865fHY-17589<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS# 9003-11-6<\/td>\nPoloxamer 407<\/td>\nMCE\u8ca8\u865fHY-D1005<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#150347-59-4<\/td>\nCFSE\u87a2\u5149\u67d3\u6599<\/td>\nMCE\u8ca8\u865fHY-D0938<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS# 9025-71-2<\/td>\n\u55ae\u5be7\u9176(Tannase)<\/td>\nMCE\u8ca8\u865fHY-P2877<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS# 941678-49-5<\/td>\nRuxolitinib<\/td>\nMCE\u8ca8\u865fHY-50856<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#9002-92-0<\/td>\nPolidocanol<\/td>\nMCE\u8ca8\u865fHY-B2106<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#HY-100579<\/td>\nFerrostatin-1 (Synonyms: Fer-1)<\/td>\nMCE\u8ca8\u865f HY-100579<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#154-23-4<\/td>\n\u5152\u8336\u7d20(Catechin)<\/td>\nMCE\u8ca8\u865f HY-N0898<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS# 2225728-57-2<\/td>\nFT895\u5f37\u6548\u9078\u64c7\u6027 HDAC11 \u6291\u5236\u5291<\/td>\nMCE\u8ca8\u865f HY-112285<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS# 5471-63-6<\/td>\n1,3-\u4e8c\u82ef\u57fa\u7570\u82ef\u4e26\u544b\u5583 (DPBF)<\/td>\nMCE\u8ca8\u865f HY-W011664<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS# 2225728-57-2<\/td>\nAkaLumine hydrochloride<\/td>\nMCE\u8ca8\u865fHY-112641A<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#203115-63-3<\/td>\nWRN \u89e3\u65cb\u9176\u6291\u5236\u5291NSC 617145<\/td>\nMCE\u8ca8\u865f \u00a0HY-110185<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#2244-11-3<\/td>\nAlloxan hydrate<\/td>\nMCE\u8ca8\u865fHY-W017227<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#23491-44-3<\/td>\nHoechst 33258<\/td>\nMCE\u8ca8\u865fHY-15558<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#18883-66-4<\/td>\nStreptozotocin<\/td>\nMCE\u8ca8\u865fHY-13753<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#554435-83-5<\/td>\nDeferasirox (Fe3+ chelate)<\/td>\nMCE\u8ca8\u865f\u00a0HY-16564<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#124-20-9<\/td>\nSpermidine<\/td>\nMCE\u8ca8\u865f\u00a0HY-B1776<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#298-83-9<\/td>\nNBT<\/td>\nMCE\u8ca8\u865fHY-15925<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#298-83-9<\/td>\nBCIP<\/td>\nMCE\u8ca8\u865f HY-15909<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#35013-72-0<\/td>\n\u751f\u7269\u7d20-NHS(Biotin-NHS)<\/td>\nMCE\u8ca8\u865f HY-D0802<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS# 25988-63-0<\/td>\nPoly-L-lysine hydrobromide<\/td>\nMCE\u8ca8\u865f HY-126437C<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS# 1898-66-4<\/td>\n\u6297\u6c27\u5316\u5291\u8207\u81ea\u7531\u57fa\u6e05\u9664\u6d3b\u6027\u6e2c\u91cf-DPPH<\/td>\nMCE\u8ca8\u865f HY-112053<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#92214-54-5<\/td>\n12-O-Tiglylphorbol-13-isobutyrate<\/td>\nMCE\u8ca8\u865f HY-107227<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS# 9001-73-4<\/td>\nPapain<\/td>\nMCE\u8ca8\u865f HY-P1645<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS#1069-66-5<\/td>\nValproic acid sodium<\/td>\nMCE\u8ca8\u865f HY-10585A<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n
MCE(MedChemexpress)<\/td>\nCAS# 1391194-67-4<\/td>\n(2R)-Octyl-\u03b1-hydroxyglutarate<\/td>\nMCE\u8ca8\u865f HY-103641<\/td>\n\u7522\u54c1\u9023\u7d50<\/a><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

\u7814\u7a76\u7d1a\u751f\u7269\u76f8\u4f3c\u85e5\u6297\u9ad4(research-grade biosimilar antibodies)\u00a0 MedCh […]<\/p>\n","protected":false},"author":3,"featured_media":52093,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[5369],"tags":[6867,6502,6866,6869,6865,6868],"_links":{"self":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/48186"}],"collection":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=48186"}],"version-history":[{"count":20,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/48186\/revisions"}],"predecessor-version":[{"id":52665,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/48186\/revisions\/52665"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/media\/52093"}],"wp:attachment":[{"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=48186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=48186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=48186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}